M. Ross Johnson

M. Ross Johnson discloses dealings in 2 companies, chiefly Savara Inc and RespireRx Pharmaceuticals Inc. The record holds 3 filings, for trades running from 21 December 2006 to 14 November 2007.

Purchases make up the whole of the open-market record (1 purchase, €10k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 2 share grants. In 2007 alone, the filings show 1 purchase and no sales.

On 14 November 2007 came the latest disclosure, an open-market purchase for €10k in RespireRx Pharmaceuticals Inc. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.